ʻO Ashwagandha

Anter

• E kūpono paha no ...
• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO Ashwagandha kahi ulu liʻiliʻi mau loa. Ulu ia ma India, ka Hikina Waena, a me nā ʻāpana o ʻApelika. Hoʻohana ʻia ke aʻa a me ka berry e hana i ka lāʻau.

Hoʻohana mau ʻia ʻo Ashwagandha no ke koʻikoʻi. Hoʻohana ʻia ia ma ke ʻano he "adaptogen" no nā kūlana ʻē aʻe he nui, akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i kēia mau hoʻohana ʻē aʻe.

Mai kānalua iā ashwagandha me Physalis alkekengi. ʻIke ʻia lāua ʻelua ma ke ʻano he cherry hoʻoilo. Eia kekahi, mai huikau i ka ashwagandha me nā ginseng ʻAmelika, ginseng Panax, a i ʻole eleuthero.

ʻO ka maʻi Coronavirus 2019 (COVID-19): ʻAʻohe hōʻike maikaʻi e kākoʻo i ka hoʻohana ʻana iā ashwagandha no COVID-19. E hāhai i nā koho nohona olakino a me nā ʻano hana pale i hōʻoia ʻia ma kahi.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no ASHWAGANDHA penei:

E kūpono paha no ...

• Kaumaha. Hōʻike kekahi mau noiʻi i ka lawe ʻana i kahi aʻa aʻa ashandandha pakiaka (KSM66, Ixoreal Biomed) 300 mg ʻelua mau lā ma hope o ka meaʻai a i ʻole kahi kikoʻī kikoʻī (Shoden, Arjuna Natural Ltd.) 240 mg i kēlā me kēia lā no 60 mau lā e ʻike ʻia e hoʻomaikaʻi i nā ʻōuli o ke koʻikoʻi.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• ʻElemakule. Hōʻike ka noiʻi mua i ka lawe ʻana i kahi aʻa aʻa ashandandha i ke aʻa kōkua e hoʻomaikaʻi i ka noho maikaʻi, ka maikaʻi o ka hiamoe, a me ka makaʻala noʻonoʻo e ka liʻiliʻi a me ke kaulike o nā mea i piha i nā makahiki 65-80.
• Nā hopena hopena Metabolic i hoʻokumu ʻia e nā lāʻau antipsychotic. Hoʻohana ʻia nā antipsychotics e mālama i ka schizophrenia akā hiki iā lākou ke hoʻoulu i nā kiʻekiʻe o ka momona a me ke kō i ke koko. Lawe i kahi kikoʻī ashwagandha (Cap Strelaxin, M / s Pharmanza Herbal Pvt. Ltd.) 400 mg ʻekolu manawa i kēlā me kēia lā no hoʻokahi mahina e hoʻemi i nā kiʻekiʻe o ka momona a me ke kō i ke koko i ka poʻe e hoʻohana ana i kēia mau lāʻau.
• Hopohopo. Hōʻike kekahi mau noiʻi mua i ka lawe ʻana i ka ashwagandha hiki ke hōʻemi i kekahi mau ʻōuli o ke ʻano pīhoihoi.
• Hana Athletic. Hōʻike kekahi mau noiʻi e lawe ana i ka ashwagandha i ka nui o ka oxygen e hiki i ke kino ke hoʻohana i ka wā hoʻoikaika kino. Akā ʻaʻole ʻike ʻia inā kōkua kēia i ka hoʻomaikaʻi ʻana i ka hana.
• Bipolar kāna hana. Lawe i kahi ʻāpana ashwagandha kikoʻī (Sensoril, Natreon, Inc.) no 8 mau pule e hoʻomaikaʻi paha i ka hana lolo i ka poʻe e mālama ʻia no ka maʻi bipolar.
• Luhi i ka poʻe i mālama ʻia me nā lāʻau ʻaʻai. Hōʻike ka noiʻi mua i ka lawe ʻana i kahi ashwagandha kikoʻī 2000 mg (Himalaya Drug Co, New Delhi, India) i ka wā o ka hoʻomaʻamaʻa chemotherapy e hōʻemi paha i ka luhi.
• Diabetes. Aia kekahi hōʻike e hōʻemi paha ʻo ashwagandha i nā pae kō kō i nā poʻe me ka maʻi kō.
• Ke ʻano o ka hopohopo hoʻomau i kahakaha ʻia e ka hopohopo nui a me ke kūpikipiki (maʻi kūpilikiʻi ākea a i ʻole GAD). Hōʻike kekahi o nā noiʻi noiʻi mua i ka lawe ʻana i ka ashwagandha hiki ke hōʻemi i kekahi mau ʻōuli o ka hopohopo.
• Kolesterol kiʻekiʻe. Aia kekahi mau hōʻike e hōʻemi paha ʻo ashwagandha i nā pae kolesterol i nā mea maʻi me ke kiʻekiʻe o ke kō.
• ʻO ka thyroid underactive (hypothyroidism). ʻO nā kānaka me ka thyroid underactive i loaʻa i ke kiʻekiʻe o ke koko o kahi hormone i kapa ʻia ʻo ka thyroid stimulate hormone (TSH). Hiki i nā poʻe me ka thyroid underactive ke loaʻa i nā pae haʻahaʻa o ka thyroid hormone. ʻO ka lawe ʻana i ka ashwagandha e hoʻohaʻahaʻa iā TSH a hoʻonui i nā kiʻekiʻe o ka hormone thyroid i ka poʻe me kahi ʻano thyroid haʻahaʻa o ka thyroid.
• ʻO Insomnia. Hōʻike kekahi noiʻi e lawe i ka ashwagandha i mea e hiamoe maikaʻi ai ka poʻe.
• Nā kūlana i loko o kahi kāne e pale iā ia mai ka hāpai ʻana i ka wahine hāpai i loko o hoʻokahi makahiki o ka hoʻāʻo ʻana e hāpai (male infertility)Hōʻike kekahi mau noiʻi mua e hiki i ka ashwagandha ke hoʻomaikaʻi i ka maikaʻi o ka sperm a me ka helu sperm i nā kāne infertile. Akā ʻaʻole maopopo inā hiki i ka ashwagandha ke hoʻomaikaʻi maoli i ka momona.
• Ke ʻano o ka hopohopo i kaha ʻia e nā manaʻo hou a me nā ʻano hana hou (obsessive-compulsive maʻi a i ʻole OCD). Hōʻike ka noiʻi mua e hiki i ka ashwagandha root root ke hōʻemi i nā ʻōuli o OCD ke lawe ʻia me nā lāʻau i kuhikuhi ʻia no 6 mau pule.
• Nā pilikia moekolohe e pale i ka hōʻoluʻolu i ka wā o ka moekolohe. Hōʻike ka noiʻi mua i ka lawe ʻana i ka ashwagandha i kēlā me kēia lā no 8 mau pule me ka loaʻa ʻana o ka ʻōlelo aʻoaʻo e hoʻonui ai i ka hoihoi i ka moekolohe a me ka hōʻoluʻolu o ka wahine i nā wahine makua me ka maikaʻi o ka moekolohe ma mua o ke aʻo ʻana wale nō.
• Ka maʻi deficit-hyperactivity maʻi (ADHD).
• Hoʻopilikia ka lolo e pili ana i ka neʻe ʻana o ka mākala (cerebellar ataxia).
• ʻO Osteoarthritis.
• Maʻi ʻo Parkinson.
• Rheumatoid arthritis (RA).
• Hoʻololi i ka hana ʻōnaehana pale.
• ʻO Fibromyalgia.
• Hoʻoulu i ka luaʻi.
• Nā pilikia ate.
• Pehu (pehu).
• Nā Tumors.
• Maʻi puʻu.
• Ulcerations, ke hoʻopili ʻia i ka ʻili.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka pono o ashwagandha no kēia mau hoʻohana.

Aia i loko o Ashwagandha nā kemika i hiki ke kōkua i ka hōʻoluʻolu o ka lolo, hoʻoliʻiliʻi i ka pehu (mumū), hoʻohaʻahaʻa i ke koko, a hoʻololi i ka ʻōnaehana pale.

Ke lawe ʻia e ka waha: ʻO Ashwagandha ʻo ia SAFE MAU PONO ke lawe ʻia a ʻekolu mau mahina. ʻAʻole ʻike ʻia ka palekana lōʻihi o ashwagandha. Hiki i nā lāʻau nui o ashwagandha ke hoʻonāukiuki i ka ʻōpū, ka palahī, a me ka luaʻi. Kākaʻikahi, hiki mai nā pilikia o ke ake.

Ke hoʻopili ʻia i ka ʻili: ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ʻo ashwagandha a he aha nā hopena ʻē aʻe.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: O ia LIKELY UNSAFE e hoʻohana iā ashwagandha ke hāpai. Aia kekahi mau hōʻike e hiki i ka ashwagandha ke hāpai i nā hānau hānau ʻole. ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ʻo ashwagandha i ka wā e hānai umauma ana. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

"Nā maʻi kūlohelohe" e like me sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), a me nā kūlana ʻē aʻe: Hoʻokumu ʻo Ashwagandha i ka ʻōnaehana pale e hana hou, a hiki i kēia ke hoʻonui i nā hōʻailona o nā maʻi auto-immune. Inā loaʻa iā ʻoe kekahi o kēia mau kūlana, ʻoi aku ka maikaʻi o ka hōʻole ʻana i ka hoʻohana ʻana iā ashwagandha.

ʻOki kino: E hoʻolohi paha ʻo Ashwagandha i ka ʻōnaehana makaʻu waena. Hopohopo nā mea mālama ola i ka anesthesia a me nā lāʻau ʻē aʻe i ka wā a ma hope o ke kaha ʻana e hoʻonui paha i kēia hopena. E hoʻōki i ka lawe ʻana i ka ashwagandha ma kahi o 2 mau pule ma mua o kahi ʻōkuhi hoʻonohonoho.

Nā maʻi thyroid: E hoʻonui paha ʻo Ashwagandha i nā pae hormone thyroid. Pono e hoʻohana akahele ʻo Ashwagandha a pale ʻia paha inā loaʻa iā ʻoe kahi kūlana thyroid a i ʻole lawe i nā lāʻau thyroid.

Kānāwai

E akahele me kēia hui ʻana.

Nā lāʻau no ka maʻi kō (Antidiabetes lāʻau)

Hiki i ka Ashwagandha ke hoʻēmi i nā pae kō kō. Hoʻohana ʻia nā lāʻau diabetes e hoʻohaʻahaʻa i ke kō kō. ʻO ka lawe ʻana iā ashwagandha me nā lāʻau diabetes e hoʻohaʻahaʻa loa ai i kāu kō kō. E nānā pono i kāu kō kō. Pono e hoʻololi i ka mahele lāʻau o kāu lāʻau diabetes.

ʻO kekahi mau lāʻau i hoʻohana ʻia no ka maʻi kō me glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, metformin (Glucophage), pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide Orinase), a me nā mea ʻē aʻe.

Nā lāʻau no ke koko kiʻekiʻe (Antihypertensive lāʻau lapaʻau)

Hoʻohaʻahaʻa paha ʻo Ashwagandha i ke kahe o ke koko ʻO ka lawe ʻana i ka ashwagandha me nā lāʻau i hoʻohana ʻia e mālama i ke koko kiʻekiʻe e hoʻohaʻahaʻa i ke kiʻekiʻe o ke koko.

ʻO kekahi mau lāʻau no ke koko kiʻekiʻe me captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), a me nā mea ʻē aʻe he nui. .

Nā lāʻau e hoʻēmi i ka ʻōnaehana pale (Immunosuppressants)

Ashwagandha me he mea lā e hana hou i ka ʻōnaehana pale. Lawe i ka ashwagandha me nā lāʻau e hōʻemi i ka ʻōnaehana pale e hoʻoliʻiliʻi paha i ka maikaʻi o kēia mau lāʻau.

ʻO kekahi mau lāʻau e hōʻemi ai i ka ʻōnaehana pale pale me azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prac506, ), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), a me nā mea ʻē aʻe.

Nā lāʻau lapaʻau hōʻoluʻolu (Benzodiazepines)

Hoʻokumu ʻo Ashwagandha i ka hiamoe a me ka hiamoe. Kapa ʻia nā lāʻau ʻo ke kumu o ka hiamoe a me ka hiamoe. ʻO ka lawe ʻana i ka ashwagandha me nā lāʻau hoʻohiamoe hiki ke hiamoe nui.

ʻO kekahi o kēia mau lāʻau hoʻohiehie e komo pū me clonazepam (Klonopin), diazepam (Valium), lorazepam (Ativan), alprazolam (Xanax), flurazepam (Dalmane), midazolam (Versed), a me nā mea ʻē aʻe.

Nā lāʻau lapaʻau hōʻoluʻolu (depressants CNS)

Hoʻokumu ʻo Ashwagandha i ka hiamoe a me ka hiamoe. ʻO nā lāʻau i kumu e hiamoe ai i kapa ʻia ʻo nā mea hōʻohi. ʻO ka lawe ʻana i ka ashwagandha me nā lāʻau hoʻohiamoe hiki ke hiamoe nui.

ʻO kekahi mau lāʻau hoʻohiehie e komo pū me clonazepam (Klonopin), lorazepam (Ativan), phenobarbital (Donnatal), zolpidem (Ambien), a me nā mea ʻē aʻe.

Hīmona thyroid

Hana maoli ke kino i nā hormone thyroid. E hoʻonui paha ʻo Ashwagandha i ka nui o ka hana a ka thyroid hormone i hana ai ke kino. ʻO ka lawe ʻana i ka ashwagandha me nā huaale hormone thyroid i kumu e nui ai ka nui o ka hormone thyroid i loko o ke kino, a hoʻonui i nā hopena a me nā hopena ʻaoʻao o ka hormone thyroid.

ʻO nā lau nahele a me nā mea hoʻopili e hoʻoliʻiliʻi i ke kahe o ke koko

Hiki i ka Ashwagandha ke hoʻohaʻahaʻa i ke kahe o ke koko. ʻO ka hoʻohui ʻana i ka ashwagandha me nā mea kanu a me nā mea hoʻopili ʻē aʻe e hoʻoliʻiliʻi hoʻi i ke kahe o ke koko e hele i ka haʻahaʻa. ʻO kekahi mau mea kanu a me nā mea hoʻopili o kēia ʻano me andrographis, casein peptides, claw o ka pōpoki, coenzyme Q-10, aila iʻa, L-arginine, lyceum, stinging nettle, theanine, a me nā mea ʻē aʻe.

Nā mea kanu a me nā mea hoʻopihapiha me nā mea hoʻohiamoe

Hiki iā Ashwagandha ke hana e like me ka mea hoʻohiamoe. ʻO ia, hiki ke hoʻonāukiuki i ka hiamoe. ʻO ka hoʻohana ʻana ia me nā mea kanu a me nā mea hoʻopili ʻē aʻe e like me ka sedatives ke kumu o ka hiamoe nui loa. ʻO kekahi o kēia mau mea me 5-HTP, calamus, California poppy, catnip, hops, Jamaican dogwood, kava, St. John's wort, skullcap, valerian, yerba mansa, a me nā mea ʻē aʻe.

ʻAʻole ʻike ʻia nā launa me nā meaʻai.

E ka waha:

• No ke koʻikoʻi: Ashwagandha aʻa unuhi 300 mg ʻelua mau manawa i kēlā me kēia lā ma hope o ka meaʻai (KSM66, Ixoreal Biomed) a i ʻole 240 mg i kēlā me kēia lā (Shoden, Arjuna Natural Ltd.) no 60 mau lā.

ʻO Ajagandha, Amangura, Amukkirag, Asan, Asana, Asgand, Asgandh, Asgandha, Ashagandha, Ashvagandha, Ashwaganda, Ashwanga, Asoda, Asundha, Asvagandha, Aswagandha, Avarada, Ayurvedic Ginseng, Cerise d'Hiver, Clustered Asteroda, Ghoda , Ginseng Indien, Hayahvaya, Indian Ginseng, Kanaje Hindi, Kuthmithi, Orovale, Peyette, Physalis somnifera, Samm Al Ferakh, Samm Al Rerakh, Sogade-Beru, Strychnos, Turangi-Ghanda, Vajigandha, Winter Cherry, Withania, Withania somnifera.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. Deshpande A, Irani N, Balkrishnan R, Benny IR. A randomized, pālua makapō, placebo kāohi hoʻopaʻa haʻawina e loiloi i nā hopena o ka ashwagandha (Withania somnifera) e lawe i ka maikaʻi o ka hiamoe i nā mākua olakino. Moe Med. 2020; 72: 28-36. Nānā kiʻi ʻole.
2. Fuladi S, Emami SA, Mohammadpour AH, Karimani A, Manteghi AA, Sahebkar A. Ka nānā ʻana i ka Withania somnifera root extract efficacy i loko o nā mea maʻi me ka maʻi o ka hopohopo maʻamau. ʻO Curr Clinic Pharmacol. 2020. E nānā abstract.
3. Björnsson HK, Björnsson ES, Avula B, et al. ʻO ka ʻeha o ke ake i hoʻokomo ʻia ʻo Ashwagandha: kahi hihia hihia mai I Islandia a me ka Pūnaewele ʻeha ʻeha ʻo Liver-Induced. ʻO Int. 2020; 40: 825-829. Nānā kiʻi ʻole.
4. ʻO Durg S, Bavage S, Shivaram SB. Withania somnifera (ginseng India) i ka maʻi diabetes: He loiloi ʻōnaehana a me nā meta-analysis o nā hōʻike ʻepekema mai ka noiʻi hoʻokolohua i ka noi lāʻau lapaʻau. ʻO Phytother Res. 2020; 34: 1041-1059. Nānā kiʻi ʻole.
5. Kelgane SB, Salve J, Sampara P, Debnath K. Ka pono a me ka hoʻomanawanui ʻana i ka ashwagandha pakiaka pakiaka i ka poʻe ʻelemakule no ka hoʻomaikaʻi ʻana i ka maikaʻi a me ka hiamoe. He prospective, randomized, double-blind, placebo-control study. Cureus. 2020; 12: e7083. Nānā kiʻi ʻole.
6. ʻO Pérez-Gómez J, Villafaina S, Adsuar JC, Merellano-Navarro E, Collado-Mateo D. Nā hopena o ashwagandha (Withania somnifera) ma VO2max: ʻO kahi ʻōnaehana ʻōnaehana a me nā ʻano hana. Nutrients. 2020; 12: 1119. Nānā kiʻi ʻole.
7. ʻO Salve J, Pate S, Debnath K, Langade D. Adaptogenic a me nā hopena hopohopo o ka ashwagandha aʻa i loko o nā mākua olakino: He makapō makapō, pani ʻia, kahi hoʻokolohua hoʻokolohua hoʻokolohua placebo. Cureus. 2019; 11: e6466. Nānā kiʻi ʻole.
8. Lopresti AL, Smith SJ, Malvi H, Kodgule R. He hoʻokolokolo e pili ana i nā hana hoʻōla kaumaha a me nā hana lāʻau o kahi Ashwagandha (Withania somnifera) i unuhi ʻia: ʻO kahi noiʻi randomized, blind-blind, placebo-control. Lapaʻau (Baltimore). 2019; 98: e17186. Nānā kiʻi ʻole.
9. Sharma AK, Basu I, Singh S. Ka hoʻokō ʻana a me ka palekana o Ashwagandha aʻa aʻa i nā mea maʻi hypothyroid subclinical: kahi makapō makapō, kahi hoʻokolokolo i hoʻokolokolo ʻia i hoʻonohonoho ʻia. J Hoʻohui Hou Med. 2018 Mar; 24: 243-248. Nānā kiʻi ʻole.
10. Kumar G, Srivastava A, Sharma SK, Rao TD, Gupta YK. ʻO ka loiloi maikaʻi a me ka palekana o ka hoʻomaʻamaʻa ayurvedic (ashwagandha pauka a me sidh makardhwaj) i nā mea maʻi rheumatoid arthritis: kahi noiʻi pilote nānā. ʻO Indian J Med Res 2015 Ian; 141: 100-6. Nānā kiʻi ʻole.
11. Dongre S, Langade D, Bhattacharyya S. Ka hoʻokō ʻana a me ka palekana o ashwagandha (withania somnifera) kumu pakiaka i ka hoʻomaikaʻi ʻana i ka hana moekolohe ma nā wahine: kahi aʻo pailaka. ʻO Biomed Res Int 2015; 2015: 284154.
12. Jahanbakhsh SP, Manteghi AA, Emami SA, Mahyari S, et al. ʻO ka loiloi i ka hopena o ka hopena o withania somnifera (ashwagandha) i nā mea maʻi me ka maʻi obsessive-compulsive: kahi hoʻokolokolo placebo-control randomized blind-blind. Hoʻohui Ther Med 2016 Aug; 27: 25-9. E ʻike i ka abstract.
13. Choudhary D, Bhattacharyya S, Joshi K. Ka mālama kino ʻana i ke kino ma nā mākua ma lalo o ke koʻikoʻi mau loa ma o ka mālama ʻana me ka ashwagandha root root: kahi makapō makapō, hoʻomohala ʻia, kahi hoʻokolokolo. J Hōʻike Hōʻikeʻike Hōʻikeʻike Altern. 2017 Ian; 22: 96-106 E nānā abstract.
14. ʻO Sud Khyati S, ʻo Thaker B. He placebo makapō makapo i hoʻonohonoho ʻia i hoʻopaʻa ʻia no ashwagandha ma ka maʻi kūpilikiʻi maʻamau. Int Ayurvedic Med J 2013; 1: 1-7.
15. ʻO Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Hoʻohui ʻia me kahi placebo i kālai ʻia me ka placeholder o withania somnifera no ka maʻi noʻonoʻo i ka maʻi bipolar. ʻO J Clin Psychiatry. 2013; 74: 1076-83. Nānā kiʻi ʻole.
16. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-control study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in diminucing stress and hopohopo i nā mākua. ʻO India J Psychol Med. 2012; 34: 255-62. Nānā kiʻi ʻole.
17. Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Ka hopena o Withania somnifera (Ashwagandha) i ka hoʻomohala ʻana i ka luhi chemotherapy-i hoʻokomo ʻia a me ka maikaʻi o ke ola i nā maʻi maʻi maʻi umauma. Hoʻohui Kanser Ther. 2013; 12: 312-22. Nānā kiʻi ʻole.
18. Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A. Nānā Haukino o ka hana Spermatogenic o ka Root Extract o Ashwagandha (Withania somnifera) ma Oligospermic Males: ʻO kahi Pilot Study. Hōʻike Hoʻohui Hōʻike Hou Med. 2013; 2013: 571420. Nānā kiʻi ʻole.
19. Agnihotri AP, Sontakke SD, Thawani VR, Saoji A, Goswami VS. Nā hopena o Withania somnifera i nā mea maʻi o schizophrenia: kahi makapō, makapō makapō, kahi placebo hoʻomalu hoʻokolohua hoʻokolohua. ʻO India J Pharmacol. 2013; 45: 417-8. Nānā kiʻi ʻole.
20. ʻO Anbalagan K a me Sadique J. Withania somnifera (ashwagandha), kahi lāʻau lapaʻau hoʻoulu hou e kaohi ai i ka alpha-2 macroglobulin synthesis i ka wā o ka mumū. Int.J. ʻO Crude Drug Res. 1985; 23: 177-183.
21. Venkataraghavan S, Seshadri C, Sundaresan TP, a me et al. ʻO ka hopena hoʻohālikelike o ka waiū i hoʻopaʻa ʻia me Aswagandha, Aswagandha a me Punarnava i nā keiki - kahi papa makapō makapō. ʻO J Res Ayur Sid 1980; 1: 370-385.
22. Ghosal S, Lal J, Srivastava R, a me et al. Nā hopena Immunomodulatory a me CNS o sitoindosides 9 a me 10, ʻelua glycowithanolides hou mai Withania somnifera. ʻImi Phytotherapy 1989; 3: 201-206.
23. Upadhaya L a me et al. Ke kuleana o kahi lāʻau ʻōiwi Geriforte ma nā pae o ke koko o nā amine biogenic a me kona mea nui i ka mālama ʻana i ka neurosis hopohopo. Acta Nerv Super 1990; 32: 1-5.
24. Ahumada F, Aspee F, Wikman G, a me et al. Withania somnifera unuhi. ʻO ka hopena ma ke kahe o ke koko arterial i nā ʻīlio anesthetized. ʻImi Phytotherapy 1991; 5: 111-114.
25. Kuppurajan K, Rajagopalan SS, Sitoraman R, a me et al. Ka hopena o Ashwagandha (Withania somnifera Dunal) i ke kaʻina o ka ʻelemakule ma nā manawaleʻa kanaka. Ka Nūpepa o ka noiʻi ma Ayurveda a me Siddha 1980; 1: 247-258.
26. Dhuley, J. N. Ka hopena o ka ashwagandha ma ka lipid peroxidation i nā holoholona i hoʻokomo ʻia i ke koʻikoʻi. ʻO J Ethnopharmacol. 1998; 60: 173-178. Nānā kiʻi ʻole.
27. Dhuley, J. N. Therapeutic efficacy o Ashwagandha e kūʻē i ka aspergillosis hoʻokolohua i nāʻiole. Immunopharmacol.Immunotoxicol. 1998; 20: 191-198. Nānā kiʻi ʻole.
28. ʻO Sharada, A. C., Solomon, F. E., Devi, P. U., Udupa, N., a me Srinivasan, K. K. Antitumor a me nā hopena radiosensitizing o withaferin A ma ka iole ʻo Ehrlich ascites carcinoma in vivo. ʻO Acta Oncol. 1996; 35: 95-100. Nānā kiʻi ʻole.
29. Devi, P. U., Sharada, A. C., a me Solomon, F. E. Antitumor a me nā hopena radiosensitizing o Withania somnifera (Ashwagandha) ma kahi tumo iole transplantable, Sarcoma-180. ʻO India J Exp Biol. 1993; 31: 607-611. Nānā kiʻi ʻole.
30. Praveenkumar, V., Kuttan, R., a me Kuttan, G. ʻO Chemoprotective hana a Rasayanas e kūʻē i ka cyclosphamide toxicity. Tumori 8-31-1994; 80: 306-308. Nānā kiʻi ʻole.
31. Devi, P. U., Sharada, A. C., a me Solomon, F. E. I ka ulu ulu vivo a me nā hopena radiosensitizing o withaferin A ma ka iole ʻo Ehrlich ascites carcinoma. Kāpena Lett. 8-16-1995; 95 (1-2): 189-193. Nānā kiʻi ʻole.
32. Anbalagan, K. a me Sadique, J. Ka hopena o kahi lāʻau lapaʻau India (Ashwagandha) ma nā mea reactant-phase reactant i ka mumū. ʻO India J Exp Biol. 1981; 19: 245-249. Nānā kiʻi ʻole.
33. Malhotra, C. L., Mehta, V. L., Prasad, K., a me Das, P. K. Haʻawina ma Withania ashwagandha, Kaul. IV. Ka hopena o nā alkaloid āpau i nā mākala maʻalahi. ʻO India J Physiol Pharmacol. 1965; 9: 9-15. Nānā kiʻi ʻole.
34. Malhotra, C. L., Mehta, V. L., Das, P. K., a me Dhalla, N. S. Haʻawina ma Withania-ashwagandha, Kaul. V. Ka hopena o nā alkaloid holoʻokoʻa (ashwagandholine) ma ka ʻōnaehana hopohopo waena. ʻO India J Physiol Pharmacol. 1965; 9: 127-136. Nānā kiʻi ʻole.
35. Begum, V. H. a me Sadique, J. Ka lōʻihi o ka hopena o ka lāʻau lāʻau Withania somnifera ma adjuvant induced arthritis i nāʻiole. ʻO India J Exp Biol. 1988; 26: 877-882. Nānā kiʻi ʻole.
36. Vaishnavi, K., Saxena, N., Shah, N., Singh, R., Manjunath, K., Uthayakumar, M., Kanaujia, SP, Kaul, SC, Sekar, K., a me Wadhwa, R. Nā hana like ʻole. o nā mea pili loa me nā withanolides, Withaferin A a me Withanone: nā bioinformatics a me nā hōʻike hoʻokolohua. PLoS.Kekahi. 2012; 7: e44419. Nānā kiʻi ʻole.
37. Sehgal, V. N., Verma, P., a me Bhattacharya, S. N. Hū ka lāʻau kūpaʻa paʻa i hoʻokumu ʻia e ashwagandha (Withania somnifera): kahi lāʻau Ayurvedic i hoʻohana ākea ʻia. Pākuʻi ʻia. 2012; 10: 48-49. Nānā kiʻi ʻole.
38. Malviya, N., Jain, S., Gupta, V. B., a me Vyas, S. Nā noi hou e pili ana i nā mea kanu aphrodisiac no ka mālama ʻana i ka hana moekolohe kāne - he loiloi. ʻO Acta Pol.Pharm. 2011; 68: 3-8. Nānā kiʻi ʻole.
39. Ven Murthy, M. R., Ranjekar, P. K., Ramassamy, C., a me Deshpande, M.ʻO ke kumu ʻepekema no ka hoʻohana ʻana i nā mea kanu lāʻau ayurvedic India i ka mālama ʻana i nā maʻi neurodegenerative: ashwagandha. Cent.Nerv.Syst. Hāʻawi iā Med.Chem. 9-1-2010; 10: 238-246. Nānā kiʻi ʻole.
40. ʻO Bhat, J., Damle, A., Vaishnav, P. P., Albers, R., Joshi, M., a me Banerjee, G. I ka hoʻomaikaʻi ʻana i ka hana o ka cell killer ma o ka ti i hoʻopaʻa ʻia me nā mea kanu Ayurvedic. Phytother.Res 2010; 24: 129-135. Nānā kiʻi ʻole.
41. Mikolai, J., Erlandsen, A., Murison, A., Brown, K. A., Gregory, W. L., Raman-Caplan, P., and Zwickey, H. L. In vivo effects of Ashwagandha (Withania somnifera) extract on the activation of lymphocytes. J.Altern. Hoʻohui Med. 2009; 15: 423-430. Nānā kiʻi ʻole.
42. Lu, L., Liu, Y., Zhu, W., Shi, J., Liu, Y., Ling, W., a me Kosten, T. R. ʻO ka lāʻau kuʻuna i ka mālama ʻana i ka lāʻau lapaʻau. Hana hoʻomake ʻino ʻA Am ​​J 2009; 35: 1-11. Nānā kiʻi ʻole.
43. Singh, R. H., Narsimhamurthy, K., a me Singh, G. Neuronutrient hopena o Ayurvedic Rasayana therapy i ka lolo ʻelemakule. ʻO Biogerontology. 2008; 9: 369-374. Nānā kiʻi ʻole.
44. Tohda, C. [Ke kūleʻa nei i nā maʻi neurodegenerative e nā lāʻau kūpuna: ka hoʻomohala ʻana i nā lāʻau lapaʻau a me nā ʻano hana pathophysiological unraveling]. Yakugaku Zasshi 2008; 128: 1159-1167. Nānā kiʻi ʻole.
45. Deocaris, C. C., Widodo, N., Wadhwa, R., a me Kaul, S. C. Hoʻohui ʻia o ayurveda a me nā moʻomeheu hana e pili ana i ka moʻomeheu kikoʻī: nā hoʻoulu mai ka biology ʻōnaehana. J.Transl.Med. 2008; 6:14. Nānā kiʻi ʻole.
46. Kulkarni, S. K. a me Dhir, A. Withania somnifera: he ginseng India. Prog.Neuropsychopharmacol.Biol.Psychiatry 7-1-2008; 32: 1093-1105. Nānā kiʻi ʻole.
47. Choudhary, MI, Nawaz, SA, ul-Haq, Z., Lodhi, MA, Ghayur, MN, Jalil, S., Riaz, N., Yousuf, S., Malik, A., Gilani, AH, a me ur- ʻO Rahman, A. Withanolides, kahi papa hou o nā kūpē cholinesterase kūlohelohe me nā waiwai antagonistic calcium. ʻO Biochem.Biophys.Res Commun. 8-19-2005; 334: 276-287. Nānā kiʻi ʻole.
48. ʻO Khattak, S., Saeed, Ur Rehman, Shah, H. U., Khan, T., a me Ahmad, M. In vitro enzyme inhibitions nā hana o nā hua ethanolic crude i kiʻi ʻia mai nā mea kanu lāʻau lapaʻau o Pakistan. Nat.Prod.Res 2005; 19: 567-571. Nānā kiʻi ʻole.
49. Kaur, K., Rani, G., Widodo, N., Nagpal, A., Taira, K., Kaul, SC, a me Wadhwa, R. Loiloi i nā hana anti-proliferative a anti-oxidative o ka lau i lawe ʻia mai loko Ua hāpai ʻo vivo a me in vitro iā Ashwagandha. ʻO Chem Chem.Toxicol. 2004; 42: 2015-2020. Nānā kiʻi ʻole.
50. Devi, P. U., Sharada, A. C., Solomon, F. E., a me Kamath, M. S. I ka ulu ulu vivo hopena o Withania somnifera (Ashwagandha) ma kahi tumo iole transplantable, Sarcoma 180. ʻO Indian J Exp Biol. 1992; 30: 169-172. Nānā kiʻi ʻole.
51. ʻO Gupta, S. K., Dua, A., a me Vohra, B. P. Withania somnifera (Ashwagandha) hoʻonāukiuki i ka pale antioksant i nā kaula o ke kuamoʻo kahiko a kāpae i ka lipid peroxidation i hoʻohuli ʻia a me nā protein oxidative. Laau Pūnaewele Metabol. 2003; 19: 211-222. Nānā kiʻi ʻole.
52. ʻO Bhattacharya, S. K. a me Muruganandam, A. V. Adaptogenic hana a Withania somnifera: kahi hoʻokolohua hoʻokolohua e hoʻohana ana i kahi hiʻohiʻona iole o ke kaumaha mau. ʻO Pharmacol Biochem. Behav 2003; 75: 547-555. Nānā kiʻi ʻole.
53. ʻO Davis, L. a me Kuttan, G. Ka hopena o Withania somnifera ma DMBA i hoʻokomo ʻia i ka maʻi kanesa. ʻO J Ethnopharmacol. 2001; 75 (2-3): 165-168. Nānā kiʻi ʻole.
54. ʻO Bhattacharya, S. K., Bhattacharya, A., Sairam, K., a me Ghosal, S. Anxiolytic-antidepressant hana a Withania somnifera glycowithanolides: kahi hoʻokolohua hoʻokolohua. Phytomedicine 2000; 7: 463-469. Nānā kiʻi ʻole.
55. Panda S, Kar A. Hoʻololi i ka nui o ka nui o ka hormone thyroid ma hope o ka lawe ʻia ʻana o ka aa root ashandandha i nā ʻiole kāne kāne makua. ʻO J Pharm Pharmacol 1998; 50: 1065-68. Nānā kiʻi ʻole.
56. Panda S, Kar A. Withania somnifera a me Bauhinia purpurea i ka hoʻoponopono ʻana o ka hoʻopuni ʻana i ka nui o ka nui o ka hormone thyroid i nāʻiole wahine. ʻO J Ethnopharmacol 1999; 67: 233-39. Nānā kiʻi ʻole.
57. Agarwal R, Diwanay S, Patki P, Patwardhan B. Nā noiʻi e pili ana i ka hana immunomodulatory o Withania somnifera (Ashwagandha) i nā mea i loaʻa i ka hoʻowalewale pale maʻi. ʻO J Ethnopharmacol 1999; 67: 27-35. Nānā kiʻi ʻole.
58. Ahumada F, Aspee F, Wikman G, Hancke J. Withania somnifera exract. ʻO nā hopena ma ke kahe o ke koko arterial i nā ʻīlio anesthetized. Phytother Res 1991; 5: 111-14.
59. Kulkarni RR, Patki PS, Jog VP, et al. Hoʻomaʻamaʻa ʻana i ka osteoarthritis me kahi mea kanu herbomineral: kahi makapō makapō, kahi placebo-kāohi ʻia, kahi aʻo keʻa. ʻO J Ethnopharmacol 1991; 33: 91-5. Nānā kiʻi ʻole.
60. Ahmad MK, Mahdi AA, Shukla KK, et al. Hoʻomaikaʻi ʻo Withania somnifera i ka maikaʻi semen ma o ka hoʻoponopono ʻana i nā pae hormone reproductive a me ke koʻikoʻi oxidative i ka plasma seminal o nā kāne hānau ʻole. Fertil Steril 2010; 94: 989-96. Nānā kiʻi ʻole.
61. Andallu B, Radhika B. Hypoglycemic, diuretic a me hypocholesterolemic hopena o ka hoʻoilo cherry (Withania somnifera, Dunal) aʻa. ʻO Indian J Exp Biol 2000; 38: 607-9. Nānā kiʻi ʻole.
62. ʻO Sriranjini SJ, Pal PK, Devidas KV, Ganpathy S. Hoʻonui o ke kaulike i ka holomua degenerative cerebellar ataxias ma hope o Ayurvedic therapy: kahi hōʻike mua. ʻO Neurol India 2009; 57: 166-71. Nānā kiʻi ʻole.
63. ʻO Katz M, Levine AA, Kol-Degani H, Kav-Venaki L. He hoʻomākaukau mea kanu (CHP) i ka mālama ʻana i nā keiki me ADHD: kahi hoʻokolokolo i kāohi ʻia. ʻO J Atten Disord 2010; 14: 281-91. Nānā kiʻi ʻole.
64. Cooley K, Szczurko O, Perri D, et al. Mālama ʻo Naturopathic no ka hopohopo: kahi hoʻāʻo loiloi ISRC TN78958974. PLoS Hoʻokahi 2009; 4: e6628. Nānā kiʻi ʻole.
65. ʻO Dasgupta A, Tso G, Wells A. Ka hopena o ka ginseng ʻĀsia, ginseng Siberian, a me ka lāʻau ayurvedic India Ashwagandha ma ke ana digoxin serum e Digoxin III, kahi immunoassay digoxin hou. ʻO J Clin Lab Anal 2008; 22: 295-301. Nānā kiʻi ʻole.
66. ʻO Dasgupta A, Peterson A, Wells A, Actor JK. Ka hopena o ka lāʻau Ayurvedic India Ashwagandha ma ke ana ʻana o ka serox digoxin a me 11 mau lāʻau e nānā pinepine ʻia e hoʻohana ana i nā immunoassay: ke aʻo ʻana i ka hoʻopaʻa ʻana o ka protein a me ka pilina me Digibind. Arch Pathol Lab Med 2007; 131: 1298-303. Nānā kiʻi ʻole.
67. Mishra LC, Singh BB, Dagenais S. kumu ʻepekema no ka hoʻohana therapeutic o Withania somnifera (ashwagandha): he loiloi. Altern Med Rev 2000; 5: 334-46. Nānā kiʻi ʻole.
68. Nagashayana N, Sankarankutty P, Nampoothiri MRV, et al. Ka hui o l-DOPA me ke ola hou ʻana ma hope o ka lāʻau Ayurveda i ka maʻi ʻo Parkinson. ʻO J Neurol Sci 2000; 176: 124-7. Nānā kiʻi ʻole.
69. ʻO Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant hana o glycowithanolides mai Withania somnifera. ʻO Indian J Exp Biol 1997; 35: 236-9. Nānā kiʻi ʻole.
70. ʻO Davis L, ʻo Kuttan G. Ka hopena Suppressive o cyclophosphamide i hoʻoweliweli ʻia e Withania somnifera extract i nāʻiole. ʻO J Ethnopharmacol 1998; 62: 209-14. Nānā kiʻi ʻole.
71. Archana R, Namasivayam A. Antistressor hopena o Withania somnifera. ʻO J Ethnopharmacol 1999; 64: 91-3. Nānā kiʻi ʻole.
72. ʻO Davis L, ʻo Kuttan G. Ka hopena o Withania somnifera ma ka cyclophosphamide-i hoʻokomo ʻia urotoxicity. Kaʻu Lett 2000; 148: 9-17. Nānā kiʻi ʻole.
73. Upton R, hoʻoponopono. ʻO Ashwagandha Root (Withania somnifera): Nānā, ka mālama ʻana i ka maikaʻi, a me ka monograph therapuetic. Santa Cruz, CA: American Herbal Pharmacopoeia 2000: 1-25.
74. McGuffin M, Hobbs C, Upton R, Goldberg A, huaʻōlelo. ʻO ka puke lima palekana palekana botanical ʻAmelika Hui Pū ʻIa ʻAmelika. ʻO Boca Raton, FL: CRC Press, LLC 1997.

Nānā hope - 12/16/2020